The 2012 Briganti nomogram not only predicts lymph node involvement but also disease progression in surgically treated intermediate-risk prostate cancer patients with PSA <10 ng/mL, ISUP grade group 3, and clinical stage up to cT2b

Author:

Porcaro Antonio Benito1ORCID,Panunzio Andrea2,Orlando Rossella1,Montanaro Francesca1,Baielli Alberto1,Artoni Francesco1,Gallina Sebastian1,Bianchi Alberto1,Mazzucato Giovanni1,Serafin Emanuele1,Patuzzo Giulia Marafioti1,Veccia Alessandro1,Rizzetto Riccardo1,Brunelli Matteo1,Migliorini Filippo1,Bertolo Riccardo1,Tafuri Alessandro2,Cerruto Maria Angela1,Antonelli Alessandro1

Affiliation:

1. University of Verona, Italy

2. Vito Fazzi Hospital, Italy

Publisher

FapUNIFESP (SciELO)

Reference24 articles.

1. EAU Guidelines on Prostate Cancer. Edn. presented at the EAU Annual Congress Milan 2023. EAU Guidelines Office, Arnhem, The Netherland,2023

2. NCCN Clinical Practice Guidelines in Oncology, Prostate Cancer, version 4,2023

3. Variability in Outcomes for Patients with Intermediate-risk Prostate Cancer (Gleason Score 7, International Society of Urological Pathology Gleason Group 2-3) and Implications for Risk Stratification: A Systematic Review;Kane CJ;Eur Urol Focus,2017

4. Favorable vs Unfavorable Intermediate-Risk Prostate Cancer: A Review of the New Classification System and Its Impact on Treatment Recommendations;Serrano NA;Oncology (Williston Park),2016

5. Intermediate-risk Prostate Cancer: Stratification and Management;Preisser F;Eur Urol Oncol,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3